Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1Global Biodefense StaffApril 26, 2026
Medical Countermeasures UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next PandemicGlobal Biodefense StaffApril 23, 2026
USF Researchers Play Key Role in Discovery of New Drug to Combat Malaria Medical Countermeasures March 25, 2013 …
FDA Approves First Antitoxin to Neutralize All 7 Botulism Serotypes Medical Countermeasures March 25, 2013 …
Nanotherapeutics Awarded $135M for Medical Countermeasures Advanced Development Defense + Military March 23, 2013 …
Anthrax Vaccine Trial for Kids? The Ethics of Pediatric Countermeasures Research Medical Countermeasures March 19, 2013 …
JPM-TMT Seeks Solutions to Multi-Drug Resistant Biowarfare Agents Antimicrobial Resistance March 12, 2013 …
Industry Day for Advancing Medical Countermeasure Regulatory Science Contracts + Grants March 11, 2013 …
Ragon Institute Brings New Perspectives to Vaccine Development Medical Countermeasures March 4, 2013 …
SEB Biodefense Vaccine Starts First Human Clinical Trial Antimicrobial Resistance February 26, 2013 …
